ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 616960 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 616960; 2) Community: the network communities that were significantly associated with the response to NSC 616960; 3) Molecule: the relationships between components within communities and NSC 616960; 4) MDR: the compounds that were significantly associated with the NSC 616960.

NSC Compound Enrichment Correlation
NSC 697859 Null 0.0171490505199911 0.37415897
NSC 701639 Null 0.0171490505199911 0.38496257
NSC 728040 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline 0.0171490505199911 0.45128995
NSC 737671 6-(3-Aminopropyl)-5,6-dihbydro-3-nitro-5,11-dioxo-9-phenyl-1 1H[1,2-c]isoquinoline Hydrochloride 0.0171490505199911 0.33862213
NSC 743244 Null 0.0171490505199911 0.49476479
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0171490505199911 0.23778847
NSC 756833 Null 0.0171490505199911 -0.43791372
NSC 759322 MEVASTATIN 0.0171490505199911 -0.054553668
NSC 625539 Iron, trichloro[phenyl-2-pyridinylmethanone(2-pyridinyl-hydrazonato)]- 0.0177048892222172 0.42703893
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.0177048892222172 0.51905312
Total:125  Current:61    [First] [Prev] [Next] [Last]